Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1439-099X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits? ; day:13 ; month:4 ; year:2022 ; pages:1-10
Strahlentherapie und Onkologie ; (13.4.2022), 1-10
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00066-022-01929-y
- URN
-
urn:nbn:de:101:1-2022062822191387391206
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schiffner, Christoph
- Christiansen, Hans
- Brandes, Iris
- Grannas, Gerrit
- Wichmann, Jörn
- Merten, Roland
- SpringerLink (Online service)
Other Objects (12)
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
Analysis of ctDNA in rectal cancer patients undergoing neoadjuvant radiochemotherapy (NeoRect trial)
Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
Analysis of ctDNA in rectal cancer patients undergoing neoadjuvant radiochemotherapy (NeoRect trial)
Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
Analysis of ctDNA in rectal cancer patients undergoing neoadjuvant radiochemotherapy (NeoRect trial)
Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer